Wilkinson Global Asset Management LLC Edwards Lifesciences Corp Transaction History

Wilkinson Global Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$68.3 - $87.44 $17 Million - $21.7 Million	-248,402 Reduced 98.88%	2,825 $210,000
Q3 2022 Oct 19, 2022	SELL	$82.37 - $107.29 $185,332 - $241,402	-2,250 Reduced 0.89%	251,227 $20.8 Million
Q2 2022 Jul 26, 2022	SELL	$86.5 - $128.27 $1.4 Million - $2.08 Million	-16,225 Reduced 6.02%	253,477 $24.1 Million
Q1 2022 May 09, 2022	BUY	$101.96 - $128.34 $52,509 - $66,095	515 Added 0.19%	269,702 $31.7 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $44,569 - $54,754	419 Added 0.16%	269,187 $34.9 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $425,327 - $507,325	-4,133 Reduced 1.51%	268,768 $30.4 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $129,448 - $161,749	-1,544 Reduced 0.56%	272,901 $28.3 Million
Q1 2021 Apr 28, 2021	BUY	$78.68 - $90.67 $21.6 Million - $24.9 Million	274,445 New	274,445 $23 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Wilkinson Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wilkinson Global Asset Management LLC with notifications on news.